Piramal Pharma Limited (NSE:PPLPHARMA)
India
· Delayed Price · Currency is INR 214.84
+2.84 (1.34%)
May 13, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 281.06 billion as of May 13, 2025. Its market cap has increased by 49.56% in one year.
Market Cap
281.06B
Enterprise Value
324.84B
Revenue
89.49B
Ranking
n/a
PE Ratio
722.52
Stock Price
214.84
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 281.06B, an increase of 23.96%. That is a compound annual growth rate of 8.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 284.82B | -19.31% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,045.76B |
| Divi's Laboratories | 1,577.41B |
| Cipla | 1,220.83B |
| Mankind Pharma | 1,031.45B |
| Apollo Hospitals Enterprise | 995.85B |
| Zydus Lifesciences | 890.37B |
| Aurobindo Pharma | 700.39B |
| Alkem Laboratories | 600.28B |